Impact of a Bi-annual CDTI on the Incidence of Epilepsy in an Onchocerciasis-endemic Area

计划入组 6,500 人 · 首次发布于 2023 年 3 月 1 日

Effect of Onchocerciasis Elimination Measures on the Incidence of Epilepsy in Maridi, South Sudan

计划入组 17,000 人 · 首次发布于 2023 年 3 月 1 日

Efficacy and Safety Study of Eravacycline Compared With Levofloxacin in Complicated Urinary Tract Infections

计划入组 908 人 · 首次发布于 2013 年 11 月 8 日

COTI-58

COTI-4A

CDRI-88495

CTI BIOPHARMA

United States

CTI BioPharma Corp.

United States

CTI CLINICAL TRIAL AND CONSULTING SERVICES AUSTRALIA PTY LTD

Australia

Oncomatryx Secures €25 Million to Advance OMTX705 Clinical Trials in Metastatic Solid Tumors

Ysios Capital Launches €100M InceptionBio Fund to Catalyze Spanish Biotech Spinouts

Integra Therapeutics Raises €10.7 Million to Advance FiCAT Gene Writing Platform and CAR-T Therapies